photo walkheader_zpsd5bunpmi.png

Category Archives: Pancreatic Cancer

Cell Surface Heparan Sulfate Proteoglycan for the Earlier Diagnosis of Pancreatic Cancer

Yesterday, European researchers and those from MD Anderson Cancer Center/ University of Texas in Houston published an article in the prestigious journal, Nature, which carries the possibility of being a game-changer in the earlier diagnosis and consequent treatment of pancreatic cancer (ductal adenocarcinoma of the pancreas). It is difficult to overstate the potential for significant […]

Locally Advanced Pancreatic Cancer: Induction Chemo with Whipple Procedure + Vascular Targets

In a certain way, the initial treatment considerations for local and advanced pancreatic cancer (ductal adenocarcinoma of the pancreas) are not as complex as those of locally advanced pancreatic cancer. Local cancer is typically treated with surgical resection – some version of the Whipple Procedure. And the treatment of advanced pancreatic cancer is generally some […]

Clinical trial of Combination of Targeted Anti-Kras Therapy for Pancreatic Cancer

Dutch and primarily other European researchers are about to begin a human clinical trial involving a regimen of two relatively new targeted therapies (afatinib plus selumetinib) for the treatment of pancreatic cancer (ductal adenocarcinoma of the pancreas).  Afatinib is known as Gilotrif in the U.S., and is produced by the family-owned global but German-headquartered Boehringer […]

Page 8 of 38« First...678910...2030...Last »
Facebook
Facebook